Lupus Therapeutics introduces the IDEAL Initiative to fund clinical studies exploring the impact of diet and the microbiome ...

Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance (LRA), today announced a pioneering funding ...

Lupus is a chronic autoimmune disease where the body’s immune system becomes overactive and attacks healthy tissues. This condition causes inflammation, swelling, and damage to joints and body organs, ...

The history of lupus can be divided into three periods: classical, neoclassical, and modern. This article concentrates on developments in the present century which have greatly expanded our knowledge ...

Most people with lupus have antinuclear antibodies (ANAs) in their blood. But a positive ANA test doesn’t always mean lupus. The test can be positive in people with other autoimmune illnesses — ...

There are several lupus treatment options. However, there is no “best" treatment for lupus because each person living with the condition will have their own needs and goals for managing it. Lupus ...

Studies investigating what is damaging the kidney in lupus nephritis point to tubulointerstitial inflammation.

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

We investigate how candidate pathogenic bacteria in gut communities affect the immune system and potentially affect autoimmune disease activity.